KATRICE ROPER: Open Payments
NPI 1265618011 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 39 payments from 7 companies in 2025. Trend: 2023 $100 · 2024 $1,722 · 2025 $2,075
Food & beverage: $2,075
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $565 |
| Teva Pharmaceuticals USA, Inc. | 10 | $560 |
| Janssen Pharmaceuticals, Inc | 3 | $281 |
| Axsome Therapeutics, Inc. | 2 | $235 |
| Indivior Inc. | 2 | $155 |
| Otsuka America Pharmaceutical, Inc. | 5 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $139 |
Products named: VRAYLAR, UZEDY, INVEGA SUSTENNA, Auvelity, SUBLOCADE, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
